New Jersey controlled-substance statute
Reference copy of New Jersey controlled-substance schedules.
Open sourceNo. Psilocybin mushrooms remain illegal statewide in New Jersey in 2026; pending bills have not created legal access.
Psilocybin mushrooms are Schedule I in New Jersey under NJSA 24:21-5. No decriminalization has passed at the state level. Multiple pending bills would create a licensed therapeutic-access program similar to Oregon's Measure 109. Until legislation passes, possession or distribution of psilocybin — including edibles and gummies — is a criminal offense under New Jersey law.
Reference copy of New Jersey controlled-substance schedules.
Open sourceOfficial source for New Jersey psilocybin and psychedelic-access bills.
Open sourceAs of 2026, New Jersey does not have a licensed psilocybin access program. Legal options for residents include:
Get notified when New Jersey's psychedelic laws change
Bills, votes, and effective dates — delivered when they happen.
No. Psilocybin mushrooms remain illegal statewide in New Jersey in 2026; pending bills have not created legal access.
No. Psilocybin is Schedule I under New Jersey Statutes Annotated §24:21-5. No decriminalization or licensed program exists. Multiple access bills are pending (S2283, S3641) but none have passed.
No. Psilocybin and psilocybin-containing mushrooms are Schedule I controlled substances under NJSA 24:21-5. Possession or distribution is a criminal offense. No New Jersey city has enacted a decriminalization or deprioritization measure. Multiple pending bills — including S2283 (Psilocybin Behavioral Health Access and Services Act) and S3641 (2025) — would create a licensed therapeutic access model, but none have passed.
No. Whether in mushroom, gummy, capsule, chocolate, or any other form, psilocybin is Schedule I in New Jersey. The form of delivery does not change the legal status.
S2283 and companion bills would create a licensed psilocybin services program similar to Oregon's, allowing trained facilitators to administer psilocybin sessions at licensed facilities. Adults would not need a prescription. The model is therapeutic access, not retail. No bill has passed as of 2026.
Suggest a tool, topic, or improvement that would make this site more useful.